GENE ONLINE|News &
Opinion
Blog

Boehringer Ingelheim
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Boehringer, Kinoxis Ink $181 Million Pact To Target Oxytocin Receptors
2023-05-08
Boehringer to Leverage RetinAI’s AI Tech to Further Geographic Atrophy Research
2023-04-23
JPM23: Partnerships Take off From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
Eli Lilly and BI Notch Clinical Win for Kidney Disease Drug
2022-11-07
Boehringer Ingelheim, Evotec and bioMérieux Form $40M Venture to Combat Antimicrobial Resistance
2022-07-07
Eli Lilly and Boehringer Ingelheim’s Jardiance Shows Encouraging Phase 3 HFpEF Data
2021-07-07
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Boehringer Ingelheim’s Ofev Becomes First FDA Approved Treatment for Progressive Interstitial Lung Diseases
2020-03-11
Boehringer Ingelheim’s New Drug – Nintedanib – Lowers Pulmonary Fibrosis by 57%
2019-10-21
Weekly in Asia 2019|JULY
2019-07-11
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top